Apoptosis: Opportunities in Cancer and Other Diseases
Apoptosis: Opportunities in Cancer and Other Diseases (February 2009)
This report focuses on apoptosis-modulating drugs in cancer, CNS disorders and chronic inflammation/autoimmunity
Apoptosis: Opportunities in Cancer and Other Diseases (February 2009)
This report focuses on apoptosis-modulating drugs in cancer, CNS disorders and chronic inflammation/autoimmunity
Apoptosis: Opportunities in Cancer and Other Diseases
Authors Sreten Bogdanovic and Beata Langlands
Pages 310
37 Tables and 3 Figures
Brochure with Table of Contents and Executive Summary
Contents
Chapter 1 Apoptosis and its regulation
Chapter 2 Assays and biomarkers of apoptosis
Chapter 3 Indirect apoptogens in development for cancer
Chapter 4 Direct apoptogens in development for cancer
Chapter 5 Other apoptosis modulators in development
Chapter 6 Commercial Outlook: Patent and Market Analysis
Chapter 7 Trends and opportunities
The following other reports offer comprehensive assessments of the therapy areas most relevant to this report:
Cancer:
Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015
Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and Market Forecasts to 2015
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015
Renal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Cervical Cancer - Pipeline Analysis and Market Forecasts to 2016
Multiple Myeloma - Drug Pipeline Analysis and Market Forecasts to 2016
Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Breast Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Bladder Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Acute Myeloid Leukemia - Drug Pipeline Analysis and Market Forecasts to 2016
Brain Tumor - Drug Pipeline Analysis and Market Forecasts to 2016
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Stomach Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Pancreatic Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
CNS Disorders:
Alzheimer’s Disease - Drug Pipeline Analysis and Market Forecasts to 2015
Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015
Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015
Muscular Dystrophy - Drug Pipeline Analysis and Market Forecasts to 2016
Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
Chronic inflammation/autoimmunity:
Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015
Psoriasis - Drug Pipeline Analysis and Market Forecasts to 2015
Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
Atopic Dermatitis - Drug Pipeline Analysis and Market Forecasts to 2016
Osteoarthritis - Drug Pipeline Analysis and Market Forecasts to 2016
Macular Degeneration - Drug Pipeline Analysis and Market Forecasts to 2016